S. Agatonovic-Kustrin and J. V. Turner Pages 943 - 951 ( 9 )
This review will discuss the structural determinants and requirements necessary for estrogen receptors alpha and beta selectivity and ligand-receptor binding affinity. In addition, strategies likely to result in the development of a pharmacophore model that account for the differences in estrogenic effects between different ligands will be discussed.
Computer aided drug design, molecular modeling, structure-activity relationship, hormones, drug design, structure, QSAR, phytoestrogens
School of Medicine–Rural Clinical Division, The University of Queensland, Locked Bag 9009,Toowoomba QLD 4350, Australia.